Gentian News | Company | Products | Employees | Blog

The utility of the cystatin C test in diagnosing kidney disease

Written by Kristin Hart | May 12, 2021 6:39:36 AM

Webinar about cystatin C as an alternative to creatinine

In this exciting webinar a multidisciplinary panel of experts examine the clinical utility of the cystatin C test in diagnosing kidney disease. The aim of this discussion was to educate healthcare practitioners on the cystatin C testing option and help them effectively communicate the benefits of the test to their patients.

Content of the webinar:

  • Importance of Estimated GFR - Josef Coresh, MD, PhD Johns Hopkins University
  • The Epidemiological Argument for Cystatin C and Impact of GFR Staging on Medication Eligibility and Dosing - Michael Shlipak, MD, MPH San Francisco VA Health Care System and University of California, San Francisco
  • Clinical Case Examples - Michelle Estrella, MD, MHS San Francisco VA Health Care System and University of California, San Francisco
  • Barriers to widespread use of cystatin C and how to overcome them - Amy Karger, MD, PhD University of Minnesota


The webinar is sponsored by Gentian Diagnostics.

 

The Gentian Cystatin C Immunoassay

The Gentian Cystatin C Immunoassay is an open channel turbidimetric test for quantitative determination of cystatin C in human serum and plasma.

  • FDA510(k) cleared and CE-marked
  • Developed and manufactured by Gentian
  • Manufactured according to ISO 13485:2016
  • IVDR registration in progress

 

Order here:

For more information or ordering cystatin C, please fill out the form below: